Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


New Board Member For Jounce Therapeutics

Executive Summary

Cancer immunotherapy company Jounce Therapeutics Inc. has appointed Barbara G. Duncan to its board of directors. Duncan has spent the last seven years at Intercept Pharmaceuticals Inc., where she was chief financial officer and treasurer. Prior to this, she held a number of leadership roles at DOV Pharmaceutical Inc., including chief executive officer. Duncan currently also serves on the boards of Edgemont Pharmaceuticals, LLC., Medgenics Inc. and Adaptimmune.






Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts